ArticleClinics (Sao Paulo, Brazil)2026
Association between glycated hemoglobin and hematological parameters in patients with type 2 diabetes mellitus: a cross-sectional study.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlycosylated hemoglobin (HbA1c) is a critical biomarker for evaluating long-term glycemic state and diagnosing diabetes mellitus, although hematological abnormalities can affect its clinical interpretation. This study aimed to determine the association of HbA1c with hematological parameters among patients with T2DM; assess associations after adjusting for age and sex; investigate sex-specific differences; and evaluate prevalence of anemia in different glycemic control categories.
methodsThis cross-sectional study evaluated clinical data from 1,278 patients with confirmed T2DM (HbA1c ≥ 6.5%; 726 females, 552 males) aged ≥ 30 years collected between January 2020 and December 2021. Analyses included correlations, age- and sex-adjusted linear regression, interaction testing, analysis of variance, logistic regression, and Holm correction.
resultsThe mean HbA1c was 8.56 ± 1.80%. Sex-stratified analysis indicated a sex-dependent reversal in the HbA1c-Hct association, with a positive correlation in females (r = 0.106) and a negative correlation in males (r = -0.110); the interaction remained significant after correction (p = 0.035). MCHC was the hematological parameter most strongly associated with HbA1c overall (r = 0.101, adjusted p = 0.002) and remained significant after adjusting for age and sex (β = 0.095, 95% CI 0.034-0.156; adjusted p = 0.014). In males, HbA1c was inversely associated with MCV (r = -0.140, adjusted p = 0.011). The prevalence of anemia was 22.9% and was significantly higher in females than males (27.7% vs. 16.7%, p < 0.001); HbA1c was not associated with anemia (OR = 0.96, 95% CI 0.89-1.04).
conclusionsThese associations were very weak and require prospective confirmation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.